Nanomedicine Market Report 2026

Nanomedicine Market Overview

• Nanomedicine market size has reached to $375.87 billion in 2025 • Expected to grow to $786.46 billion in 2030 at a compound annual growth rate (CAGR) of 16% • Growth Driver: Nanomedicine Market Growth Fueled By Rising Burden Of Chronic Diseases • Market Trend: Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nanomedicine Market?

Nanomedicine refers to the use of nanotechnology in medicine. It is described as substances with a size between 1 and 100 nanometers that, in the end, should be able to precisely target tumor cells or important immune cells. Nanomedicine is an important instrument that enables personalized, targeted, and regenerative medicine by delivering improved new drugs, treatments, and implantable devices to clinicians and patients. The main types of nanomedicine are nanoparticles, nanoshells, nanotubes, nanodevices, and others. Nanoparticles are a type of ultrafine particles usually between 1 and 100 nanometers in diameter used in making medicine and drugs. The different forms of modality include diagnostics, treatments and are used in clinical oncology, infectious diseases, clinical cardiology, orthopedics, others.

What Is The Nanomedicine Market Growth Forecast?

The nanomedicine market size is expected to see rapid growth in the next few years. It will grow to $786.46 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to expansion of precision medicine applications, integration of ai in nanomedicine research, growth in regenerative medicine demand, increasing government funding for nanotech healthcare, development of multifunctional nanodevices. Major trends in the forecast period include targeted drug delivery innovations, regenerative nanomedicine development, personalized therapeutics expansion, nanodevice-based diagnostics, nanoformulation optimization.

Global Nanomedicine Market Segmentation

1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types 2) By Modality: Diagnostics, Treatments 3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications Subsegments: 1) By Nanoparticles: Lipid-Based Nanoparticles, Polymeric Nanoparticles, Metallic Nanoparticles, Ceramic Nanoparticles 2) By Nanoshells: Gold Nanoshells, Silver Nanoshells, Silica Nanoshells 3) By Nanotubes: Carbon Nanotubes (CNTs), Polymer Nanotubes 4) By Nanodevices: Nanosensors, Nanorobots, Nanoscale Imaging Devices 5) By Other Types: Dendrimers, Quantum Dots, Nanocarriers

What Is The Driver Of The Nanomedicine Market?

The rising burden of complex and chronic diseases across the globe is expected to contribute to the growth of the nanomedicine market in the forecast period. Nanomedicine is increasingly being used in treating chronic diseases, including cardiovascular disorders, diabetes, cancer, dementia, and others, where it helps in the fast metabolism of drugs in the body. For instance, according to the International Federation of Alzheimer's Associations, Alzheimer's Disease International, more than 50 million people are suffering from dementia globally, and it is projected to double every 20 years, which will reach 80 million by 2030 and 152 million by 2050. The total cancer burden in the world is predicted to rise to 28.4 million new cancer cases in 2040. This increasing burden of chronic diseases is expected to propel the demand for effective therapeutic treatment based on nanomedicine, thus driving the growth of the nanomedicine industry.

Key Players In The Global Nanomedicine Market

Major companies operating in the nanomedicine market are Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc.

Global Nanomedicine Market Trends and Insights

Major companies operating in the nanomedicine market are focusing on innovative products such as Dynapro ZetaStar to drive revenues in their market. The novel instrument allows for simultaneous measurements of dynamic and static light scattering as well as dynamic and electrophoretic light scattering (DLS/SLS/ELS). For instance, in September 2023, Waters Corporation, a US-based company that specializes in analytical laboratory instruments and equipment, launched Dynapro ZetaStar for nanoparticle analysis. The Zetasizer instrument helps with the accurate development of complex biologics by combining multiple light scattering techniques, performing adaptive data capture, automatically assessing data quality, and increasing sensitivity and speed of measurements while utilizing incredibly small sample volumes. The ZetaStar instrument's unique flow cell design makes it possible to connect it with an autosampler, which greatly increases laboratory productivity and efficiency by enabling dozens of unattended measurements that can be carried out for several hours or even overnight.

What Are Latest Mergers And Acquisitions In The Nanomedicine Market?

In November 2023, Celgene, a US-based company that operates as an integrated biopharmaceutical company focused on discovering and developing innovative therapies, acquired a part of Nano Precision Medical for an undisclosed amount. By acquiring a stake in Nano Precision Medical, Celgene strengthens its position in the nanomedicine market, allowing it to compete more effectively against other pharmaceutical companies that are also investing in innovative drug delivery solutions. Nano Precision Medical, a US-based company, produces miniaturized, subdermal drug implants utilizing its proprietary NanoPortal technology.

Regional Insights

North America was the largest region in the nanomedicine market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nanomedicine Market?

The nanomedicine market consists of sales of gold, silica, iron oxide, polymeric, liposomes, and micelles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nanomedicine Market Report 2026?

The nanomedicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nanomedicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.